Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2022 - 07 - 12 save search
Pliant Therapeutics Announces Pricing of Upsized $200.0 Million Public Offering
Published: 2022-07-12 (Crawled : 00:00) - globenewswire.com
PLRX | $12.2 0.08% 60K
|
Health Technology
|
| O: -0.25%
H: 2.86%
C: -6.07%
offering therapeutics
4: Statement of changes in beneficial ownership of securities
Published: 2022-07-12 (Crawled : 22:00) - allogene.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-07-12 (Crawled : 22:00) - globenewswire.com
TVTX | $5.745 -0.95% 310K
|
Health Technology
|
| O: -0.48%
H: 3.44%
C: 0.85%
nasdaq grants
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
Published: 2022-07-12 (Crawled : 22:00) - globenewswire.com
ANIK | News | $25.66 0.9% 7.5K
|
Health Technology
|
| O: -1.46%
H: 3.05%
C: 2.56%
results
Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal of Medicinal Chemistry
Published: 2022-07-12 (Crawled : 21:00) - biospace.com/
BCYC | $24.335 -0.63% 54K
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: -2.76%
bt7480 preclinical program therapeutics bicycle publication pre-clinical
Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer
Published: 2022-07-12 (Crawled : 21:00) - biospace.com/
LPTX | $2.88 -2.7% 9.3K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -8.8%
BGNE | $130.63 -1.01% 69K
|
Health Technology
|
| O: -0.58%
H: 4.0%
C: 1.51%
dkn-01 trials therapeutics leap cancer
8-K: Report of unscheduled material events or corporate event
Published: 2022-07-12 (Crawled : 21:00) - allogene.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
report
SC TO-I/A: Amendment to a previously filed SC TO-I
Published: 2022-07-12 (Crawled : 21:00) - allogene.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
3: Initial filing by director officer or owner of more than ten percent.
Published: 2022-07-12 (Crawled : 21:00) - allogene.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
Y-mAbs’ Announces Clearance of IND for GD2-SADA
Published: 2022-07-12 (Crawled : 20:00) - biospace.com/
YMAB | $14.955 -0.3% 120K
|
Health Technology
|
| O: 0.88%
H: 7.46%
C: 2.62%
clearance
Plus Therapeutics Successfully Completes Key Milestone for cGMP Manufacture of Lead Investigational Radiotherapeutic
Published: 2022-07-12 (Crawled : 20:00) - biospace.com/
PSTV | $1.67 -1.27% 4.6K
|
Health Technology
|
| O: 0.0%
H: 2.02%
C: -2.0%
therapeutics plus milestone
Worldwide Bladder Cancer Drugs Market to Reach $4.45 Billion in 2026 at a CAGR of 17.3%
Published: 2022-07-12 (Crawled : 18:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: 0.0%
H: 0.93%
C: -0.33%
ADAP | $1.04 15.76% 700K
|
Health Technology
|
| O: 0.0%
H: 4.53%
C: 2.92%
bladder cancer market drug
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer's Disease Mouse Model
Published: 2022-07-12 (Crawled : 15:00) - prnewswire.com
HOTH | $1.18 740
|
Health Technology
|
| O: -0.57%
H: 74.4%
C: 3.19%
disease alzheimer's therapeutics ht-alz
Altamira Therapeutic’s RNA Delivery Platform Shown to be an Effective Treatment for Abdominal Aortic Aneurysm as Published in Peer-Reviewed Journal
Published: 2022-07-12 (Crawled : 14:00) - biospace.com/
CYTO | $1.5 13K
|
Manufacturing
|
| O: 10.41%
H: 4.37%
C: 0.82%
treatment platform
VistaGen CEO Joins U.S. Surgeon General to Discuss Mental Health Crisis in America at the 2022 Concordia Americas Summit
Published: 2022-07-12 (Crawled : 13:20) - biospace.com/
VTGN | $4.74 0.85% 34K
|
Health Technology
|
| O: -0.57%
H: 1.37%
C: -5.58%
america ceo health
Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors
Published: 2022-07-12 (Crawled : 13:20) - allogene.com
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: 0.46%
H: 1.02%
C: 0.75%
SRPT | $115.845 -0.61% 120K
|
Health Technology
|
| O: 0.07%
H: 0.39%
C: -1.33%
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: 0.18%
H: 5.67%
C: 4.32%
therapeutics
Aldeyra Therapeutics Achieves Primary Endpoints in Dry Eye Disease Chamber Crossover Clinical Trial
Published: 2022-07-12 (Crawled : 13:00) - biospace.com/
ALDX | News | $3.85 -3.27% 130K
|
Health Technology
|
| O: 1.79%
H: 15.6%
C: 12.97%
disease eye trial therapeutics
Oncotelic Announces Presentation of P001- OT-101 Phase 1/2 Trial in Pancreatic Cancer
Published: 2022-07-12 (Crawled : 13:00) - biospace.com/
OTLC | $0.042 100K
|
Manufacturing
|
| O: 11.57%
H: 0.0%
C: -11.85%
ot-101 trial presentation cancer pancreatic phase 1
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors
Published: 2022-07-12 (Crawled : 13:00) - biospace.com/
PRAX | $46.26 -0.71% 140K
|
Health Technology
|
| O: 1.54%
H: 3.5%
C: 1.82%
therapeutics
KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER
Published: 2022-07-12 (Crawled : 13:00) - biospace.com/
KZIA | $0.3462 92K
|
Health Technology
|
| O: 0.25%
H: 0.5%
C: -0.25%
cancer train
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.